Pharmacodynamics Flashcards

1
Q

What does Pharmacodynamics study?

A

Pharmacodynamics studies the mechanism of the physiological effect of a drug and the varying magnitude.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

If drug A has a higher Emax than drug B, what is implied?

A

Emax (Efficacy) is considered the maximum effect produced by the agonist.

A higher Emax implies drug A is more Efficacious than Drug B.

That is, it has a higher ability to produce the desired or intended result.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

If Drug A has a higher ED50 than Drug B, what is implied?

A

ED50 (Potency) is the concentration of drug which produces 50% of Emax, thus it is a measure of Potency.

A higher ED50 implies that drug A is more Potent than drug B.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do potency & efficacy relate?

A

Potency (EC50) & efficacy (Emax) are independent of eachother. Neither can predict eachother.

Efficacy is usually more important in therapeutics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does higher potency imply in therapeutics?

A

Higher potency can indicate greater selectivity and thus fewer side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why not always use a dose much larger than the EC50 to insure max therapeutic effect?

A

Increasing the dose/concentration may cause adverse side effects.

In general, increasing the dose closer to the Emax increases the chance of developing adverse side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give the equation for the Dose-Response Curve

A

Dose-Response Curve:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe how the effect equation can be used to calculate an effect, given a certain concentration.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do Potency (Emax) & Efficacy (ED50) relate?

A

Potency (EC50) & efficacy (Emax) are independent of eachother. Neither can predict eachother.

Efficacy is usually more important in therapeutics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the purpose of Quantal Response curves?

What are the variables measured?

A

Quantal Response Curves are used to determine the safety of a drug.

ED measures the Efficacy

LD measures the Lethality, with LD50 indicating the dose at with 50% of the subjects die.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What quantities can be determined from Q-R curves?

A

Therapeutic Index (TI): The distance between ED50 & LD50

Margin of Safety (MofS): Distance between ED99 & LD1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If a Margin of Safety is <1, what may occur if you push to achieve maximum effect?

A

If you push to achieve maximum effect, you’ll begin killing people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Agonist Only: Curve 2

Agonist + Competitive Inhibitor (antagonist): ?

A

Agonist Only: Curve 2

Agonist + Competitive Inhibitor (antagonist): Curve 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain Curve 1

A

Curve 1 indicates a partial agonist given in the presence of a full agonist.

“At high [Partial Agonist], the response drops to the efficacy of the partial agonist as it displaces the full agonist from the receptor. A high dose of a partial agonist can lower the response to a full agonist.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the 2 potential causes of Curve 4.

A
  1. Partial Agonist
  2. Agonist + irreversible antagonist (inhibitor) compared to Curve 2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is curve 5?

A

Curve 5 is an inverse agonist

17
Q

For most drugs, how does EC50 compare to KD?

Why?

A

For most drugs EC50 < KD

This is because of the presence of spare receptors, which functions to;

  1. Increases the sensitivity of a cell to an agonist
  2. Facilitate repeated responses to an agonist & resist desensitization
18
Q

In a cell with spare receptors, how does the Binding curve compare to the Response curve?

A
19
Q

Given (3) cells with different quanities of receptors to an agonist, describe how the D-R curve would result.

A: No Spare R.

B: 1x Spare R.

C: 10x Spare R.

A

Spare receptors reduce EC50 and thus increase potency

20
Q

Comparing Partial to Full Agonists, what differs?

A

Partial Agonists have lower efficacy than Full agonists (lower Emax)

Potency can vary, independent of the full agonist

21
Q

If a Full agonist is present and a partial agonist is administered, what occurs?

A
22
Q

What is the R-> R* model?

A
23
Q

Adding a competitive antagonist to an Agonist causes what type of shift to the DR curve?

A

A parallel right shift with no effect on Emax.

24
Q

Adding an irreversible inhibitor to an Agonist causes what type of change on the DR curve?

A
25
Q
A